IL1B and cancer: Another example is canakinumab, a human monoclonal antibody that selectively targets and neutralizes the proinflammatory cytokine interleukin-1 beta (IL-1β), which plays a crucial role in various inflammatory diseases such as autoinflammatory disorders, cardiovascular diseases, and some cancers.